Mobile electrocardiographic devices and healthcare utilization in post-atrial fibrillation ablation patients.

Abstract

The use of mobile electrocardiogram (mECG) devices is becoming more prevalent. mECG devices allow instant access to recording arrhythmias and enable automatic rhythm interpretation. Providers can remotely evaluate patients and this may reduce in-person healthcare utilization. We sought to evaluate the utility of mECG devices in reducing healthcare utilization among patients who underwent atrial fibrillation (AF) ablation. We identified a population of patients with paroxysmal or persistent AF presenting for their first AF ablation. Patients were divided into two groups: KardiaMobile (AliveCor, Mountain View, CA) mECG users and non-KardiaMobile users. Healthcare utilization was compared between the two groups for one year post-ablation. 184 patients were studied (76 KardiaMobile users, 108 non-KardiaMobile users). There was no difference in the number of office visits (p=0.59), cardiac-specific emergency department visits (p=0.26), cardiac-specific hospital admissions (p=0.13), ablations or cardioversions completed (p=0.24), telephone encounters (p=0.05), patient electronic health record messages (p=0.40), or cardiac imaging (transthoracic or transesophageal echocardiograms) tests ordered (p=0.36). Exposure to the device was associated with a reduction in ambulatory cardiac monitor use (p=0.04). There was no difference in sinus rhythm maintenance over 12months by Kaplan-Meier survival analysis (log rank test p=0.05) between groups. Mobile technology is available for heart rhythm monitoring and can give instant feedback to the user. mECG use is associated with a significant reduction in ambulatory cardiac monitor use in the post-ablation period. There was no difference in other AF-related healthcare utilization.